UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029081
Receipt number R000033261
Scientific Title An in vitro investigation of coagulation effects of exogenous sugammadex using thromboelastography in orthopaedic surgical patients .
Date of disclosure of the study information 2017/09/11
Last modified on 2018/02/21 11:43:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An in vitro investigation of coagulation effects of exogenous sugammadex using thromboelastography in orthopaedic surgical patients .

Acronym

An in vitro investigation of coagulation effects of sugammadex using thromboelastography

Scientific Title

An in vitro investigation of coagulation effects of exogenous sugammadex using thromboelastography in orthopaedic surgical patients .

Scientific Title:Acronym

An in vitro investigation of coagulation effects of sugammadex using thromboelastography

Region

Asia(except Japan)


Condition

Condition

Coagulation effects of sugammadex

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate of coagualtion effects of exogenous sugammadex in surgical patients

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Thromboelastography parameters for citrated whole blood and citrated whole blood with exogenous sugammadex

Key secondary outcomes

Association between percent change of thromboelastography parameters and sugammadex concentration


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit

45 years-old >

Gender

Male and Female

Key inclusion criteria

American Society of Anesthesiologist Physical Class 1-2
Orthopaedic surgery patient

Key exclusion criteria

Patients taking aspirin or oral anticoagulant within 14 days
Platelet<100,000, PT INR>1.5, or aPTT>50 sec
Pregnant woman
Liver disease or renal disease
Surgical history within 30 days

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hae Wone Chang

Organization

Korea University Guro Hospital

Division name

Anesthesiology and Pain Medicine

Zip code


Address

148 Gurodong-ro, Guro-gu, Seoul

TEL

82226263237

Email

chelenh@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Mido Lee

Organization

Korea University Guro Hospital

Division name

Anesthesiology and Pain Medicine

Zip code


Address

148 Gurodong-ro, Guro-gu, Seoul

TEL

82226261437

Homepage URL


Email

midoyee@gmail.com


Sponsor or person

Institute

Korea University Guro Hospital
Department of Anesthesiology and Pain Medicine

Institute

Department

Personal name



Funding Source

Organization

Korea University Guro Hospital
Department of Anesthesiology and Pain Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Korea University Guro Hospital (Seoul)


Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Increased sugammadex concentrations were significantly associated with reduced coagulation, as evidenced by the increases in reaction time (r), coagulation time, and time to maximum rate of thrombus generation (TMRTG), and the decreases in the angle, maximum amplitude, and maximum rate of thrombus generation. Compared with the control, the median percentage change (interquartile range) in the TEG values of the samples with the highest exogenous sugammadex concentration was the greatest for r, 53% (26%, 67.3%), and TMRTG, 48% (26%, 59%).

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 11 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 12 Day

Last follow-up date

2017 Year 10 Month 01 Day

Date of closure to data entry

2017 Year 11 Month 29 Day

Date trial data considered complete

2017 Year 11 Month 29 Day

Date analysis concluded

2017 Year 11 Month 29 Day


Other

Other related information

Thromboelastogrpahic parameters for citrated whole blood and citrated whole blood with exogenous sugammadex


Management information

Registered date

2017 Year 09 Month 11 Day

Last modified on

2018 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033261


Research Plan
Registered date File name
2017/11/29 Research Plan.docx

Research case data specifications
Registered date File name
2017/11/29 researchdataspecification.docx

Research case data
Registered date File name
2017/11/29 data_umin.xlsx